Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative

NCT02754011 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Combination of ribociclib + capecitabine

Sponsor

UNICANCER

Collaborators

[object Object]